B of A Securities Maintains Buy on Cellebrite DI, Raises Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Tal Liani maintains a Buy rating on Cellebrite DI (NASDAQ:CLBT) and raises the price target from $12 to $13.

April 01, 2024 | 11:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities maintains a Buy rating on Cellebrite DI and increases the price target from $12 to $13.
The upgrade in the price target by a reputable analyst like Tal Liani suggests a positive outlook on Cellebrite DI's stock, likely due to anticipated performance improvements or market conditions favoring the company. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100